                         SEQUENCE LISTING

<110>  Stichting VU-VUmc
 
<120>  EBV markers and Systemic Lupus Erythematosus

<130>  P30853PC00

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  167
<212>  RNA
<213>  Epstein Barr Virus

<400>  1
aggaccuacg cugcccuaga gguuuugcua gggaggagac guguguggcu guagccaccc       60

gucccgggua caagucccgg guggugagga cggugucugu gguugucuuc ccagacucug      120

cuuucugccg ucuucgguca aguaccagcu ggugguccgc auguuuu                    167


<210>  2
<211>  173
<212>  RNA
<213>  Epstein Barr Virus

<400>  2
aggacagccg uugcccuagu gguuucggac acaccgccaa cgcucagugc ggugcuaccg       60

acccgagguc aagucccggg ggaggagaag agaggcuucc cgccuagagc auuugcaagu      120

caggauucuc uaaucccucu gggagaaggg uauucggcuu guccgcuauu uuu             173


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer EBER1

<400>  3
aggacctacg ctgccctaga                                                   20


<210>  4
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer EBER1

<400>  4
aaaacatgcg gaccacc                                                      17


<210>  5
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer EBER2

<400>  5
aggacagccg ttgccctagt ggtttc                                            26


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer EBER2

<400>  6
aaaaatagcg gacaagccga atacc                                             25


